Impact of a novel algorithm designed to reduce T-wave oversensing with the subcutaneous defibrillator in a patient with type I Brugada electrocardiogram

Slides:

Advertisements

Similar presentations

Implantation of the subcutaneous implantable cardioverter-defibrillator with retroperitoneal generator placement in a child with hypoplastic left heart.

Advertisements

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator Mohammad-Ali.

Successful use of bivalirudin in place of heparin infusion for pulmonary vein isolation using a cryoballoon catheter in a patient with heparin allergy

Ellis Rochelson, MD, Lynn Nappo, RN, Robert H. Pass, MD

Atrioventricular hysteresis pacemaker mode promoting a short-long-short sequence at the onset of ventricular tachycardia Neiberg de Alcantara Lima, MD,

Erroneous shock by an AED: Importance of obtaining AED tracing to prevent inappropriate ICD implantation Brian J. Cross, MD, Mark S. Link, MD, FHRS

Appearance of J wave in the inferolateral leads and ventricular fibrillation provoked by mild hypothermia in a patient with Brugada syndrome Yasuaki.

Isolated left bundle branch block progressing to complete heart block and asystole: A novel presentation of a desmin mutation Addison S. Gearhart, MD,

Inappropriate shock from delayed T-wave oversensing by a subcutaneous implantable cardioverter-defibrillator after septal myectomy for hypertrophic cardiomyopathy

Recurrent commotio cordis: Déjà vu

A 35-year effective treatment of catecholaminergic polymorphic ventricular tachycardia with propafenone Alexandra Marx, MD, Björn Lange, MD, Carsten.

Combination of a leadless pacemaker and subcutaneous defibrillator: First in-human report Blandine Mondésert, MD, Marc Dubuc, MD, FHRS, Paul Khairy,

Successful management of wound dehiscence after implantation of a subcutaneous implantable cardioverter-defibrillator without device removal Mitsuhiro.

Is it bradycardia or something else causing symptoms?

T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome

Use of topical lidocaine in eliminating mechanically stimulated ventricular fibrillation in a patient with short QT syndrome Maria J. Farag, BS, Joseph.

Anne Barnett, PA-C, Lee Eckhardt, MD, FHRS, Miguel A. Leal, MD, FHRS

HeartRhythm Case Reports

Respiratory rate trending as a cause for atrial lead noise: A first report in an implantable cardioverter-defibrillator patient Isla McClelland, MD,

Dichotomous roles of TBX3 in the establishment of atrioventricular conduction pathways in the human heart Hoang H. Nguyen, MD, Dorothy K. Grange, MD,

Successful detection of a high-energy electrical short circuit and a “rescue” shock using a novel automatic shocking-vector adjustment algorithm Masahiro.

Repeated molecular genetic analysis in Brugada syndrome revealed a novel disease- associated large deletion in the SCN5A gene Anders Krogh Broendberg,

Jonathan T. Jaffe, MD, Lee-Gardie Jean, MD, Richard J. Murray, MD

T-wave oversensing from postural changes: A rare cause of inappropriate shock from a subcutaneous defibrillator Muhammad R. Afzal, MD, Auroa Badin, MD,

Unusual mechanism of complete atrioventricular block following atrial flutter ablation Frederic Georger, MD, Luc De Roy, MD, Camelia Sorea, Jean-Paul.

Failure of ICD therapy in lethal arrhythmogenic right ventricular cardiomyopathy type 5 caused by the TMEM43 p.Ser358Leu mutation Kasper Aalbæk Kjærgaard,

Left axillary active can positioning markedly reduces defibrillation threshold of a transvenous defibrillator failing to defibrillate at maximum output

Low room temperature can trigger ventricular fibrillation in J wave syndromes Masaru Yamaki, MD, Nobuyuki Sato, MD, PhD, Rina Imanishi, MD, Hirotsuka.

Oral quinine sulfate for the treatment of electrical storm and prevention of recurrent shocks in Brugada syndrome after failed cilostazol therapy Jayaprakash.

Daniel P. Morin, MD, MPH, FACC, FHRS HeartRhythm Case Reports

Repeat inappropriate defibrillator discharges following defibrillator implantation. What is the mechanism and treatment? Jeremy W. Docekal, MD, Mark.

Kevin M. W. Leong, MBBS, MRCP, Henry Seligman, MBBS, MRCP, Amanda M

Complete congenital heart block: A case of multilevel block

Emilio L. Garcia, MD, Robert Kim, MD, Steve S. Hsu, MD, FHRS, John N

Recording of isolated very delayed potentials on the right ventricular epicardium in a patient with Brugada syndrome Atsuyuki Watanabe, MD, Hiroshi Morita,

An unusual approach to intractable AVNRT in a pediatric patient

Intravenous sotalol for conversion of atrial flutter in infants

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator Mohammad-Ali.

A case series and review of the literature regarding coronary artery complications associated with coronary sinus catheter ablation Paul J. Garabelli,

Simrit K. Warring, MS, Heather N. Anderson, MD, J

Successful use of bivalirudin in place of heparin infusion for pulmonary vein isolation using a cryoballoon catheter in a patient with heparin allergy

Inappropriate shocks in a patient with a subcutaneous implantable cardioverter- defibrillator Sana M. Al-Khatib, MD, MHS, FHRS, Sasmrita Belbase, NP,

Albert N. Nayeri, MD, Behzad B. Pavri, MD HeartRhythm Case Reports

Appropriate use of genetics in a young patient with atrioventricular block and family history of sudden cardiac death Johnni Rudbeck-Resdal, MD, Jens.

Air entrapment causing early inappropriate shocks in a patient with a subcutaneous cardioverter-defibrillator Sing-Chien Yap, MD, PhD, Rohit E. Bhagwandien,

Oversensing of an unexpected atrial flutter

Jay A. Montgomery, MD, Dan M. Roden, MD, FHRS HeartRhythm Case Reports

Vagally mediated ventricular arrhythmia in Brugada syndrome

Inappropriate subcutaneous implantable cardioverter-defibrillator therapy due to R-wave amplitude variation: Another challenge in device management Syeda.

An original management of focal atrial tachycardia originating from a giant left atrial appendage Stéphane Combes, MD, Jean Paul Albenque, MD, Nicolas.

Daniel W. Nelson, BS, Caroline Vloka, BA, Jule Wetherbee, MD

Progressive electrical remodeling in apical hypertrophic cardiomyopathy leading to implantable cardioverter-defibrillator sensing failure during ventricular.

Mitral valve repair results in suppression of ventricular arrhythmias and normalization of repolarization abnormalities in mitral valve prolapse Wael.

Successful implantation of a subcutaneous cardiac defibrillator in a patient with a preexisting deep brain stimulator Yousef Bader, MD, Jonathan Weinstock,

IRX3 variant as a modifier of Brugada syndrome with frequent ventricular fibrillation Yoshitaka Kimura, MD, Takeshi Aiba, MD, PhD, Tetsuo Sasano, MD,

Changing place, changing future: Repositioning a subcutaneous implantable cardioverter-defibrillator can resolve inappropriate shocks secondary to myopotential.

Subcutaneous implantable cardioverter-defibrillator implantation in a patient with bilateral pectoral deep brain stimulators Thor Tejada, MD, Faisal.

The use of noninvasive ECG imaging for examination of a patient with Brugada syndrome Maria Chaykovskaya, MD, Boris Rudic, MD, Alexey Tsyganov, MD, Elena.

The runaway defibrillator…A case of an implantable cardioverter-defibrillator that failed communication and deactivation with a magnet Mahmoud Assaad,

Unusual severe hemodynamic failure associated with standard dose of intravenous flecainide for pharmacological cardioversion of atrial fibrillation Aref.

Supraspinatus pocket: An alternative pacemaker location for patients with no prepectoral access Guillaume Abehsira, MD, Françoise Hidden-Lucet, MD, Estelle.

Implantation of the subcutaneous implantable cardioverter-defibrillator with retroperitoneal generator placement in a child with hypoplastic left heart.

Overcoming an impossible anatomy with a novel left ventricular active fixation lead in the coronary sinus: A case report Gabriele Giannola, MD, PhD,

Nanostim leadless pacemaker system: A longer waiting period after active fixation may reduce unnecessary repositioning Hiro Kawata, MD, PhD, Pranav M.

Abdul R. Mourad, MD, Michael H. Kim, MD, FHRS, Malcolm M

Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T- wave oversensing in hyperkalemia leading to ventricular fibrillation

Use of topical lidocaine in eliminating mechanically stimulated ventricular fibrillation in a patient with short QT syndrome Maria J. Farag, BS, Joseph.

Ventricular tachycardia slower than the rate cut-off of a subcutaneous cardiac defibrillator sensed and successfully treated as a result of oversensing

Mobile subcutaneous implantable cardioverter-defibrillator leads to oversensing and inappropriate shocks Omid Kiamanesh, MD, Jacob M. Larsen, MD, PhD,

Substernal subcutaneous implantable cardioverter-defibrillator lead placement for the management of inappropriate shocks Khuyen Do, MD, Chin C. Lee,

Presentation transcript:

Impact of a novel algorithm designed to reduce T-wave oversensing with the subcutaneous defibrillator in a patient with type I Brugada electrocardiogram Serge Boveda, MD, Marijke C. Laarakker, PhD, Christèle Cardin, MD, Jean-Paul Albenque, MD HeartRhythm Case Reports Volume 4, Issue 1, Pages 31-33 (January 2018) DOI: 10.1016/j.hrcr.2017.11.009 Copyright © 2017 Heart Rhythm Society Terms and Conditions

Figure 1 Surface electrocardiogram: observe the spontaneous marked ST-segment elevation in lead V1 in this patient. HeartRhythm Case Reports 2018 4, 31-33DOI: (10.1016/j.hrcr.2017.11.009) Copyright © 2017 Heart Rhythm Society Terms and Conditions

Figure 2 A: Inappropriately sensed but correctly discarded T waves (black dots) with SMART Pass off. B: In the same patient, T waves are no longer sensed with SMART Pass on and with the same sensing vector (secondary configuration). S = ventricular sensing. HeartRhythm Case Reports 2018 4, 31-33DOI: (10.1016/j.hrcr.2017.11.009) Copyright © 2017 Heart Rhythm Society Terms and Conditions